Literature DB >> 23073325

Cystic pancreatic neuroendocrine tumors: a clinicopathologic study.

Aatur D Singhi1, Linda C Chu, Armanda D Tatsas, Chanjuan Shi, Trevor A Ellison, Elliot K Fishman, Satomi Kawamoto, Richard D Schulick, Christopher L Wolfgang, Ralph H Hruban, Barish H Edil.   

Abstract

Pancreatic neuroendocrine tumors (PanNETs) are typically solid neoplasms but in rare instances may present as cystic lesions. This unusual presentation can make clinical diagnosis challenging. In addition, the clinical and histopathologic characteristics of cystic PanNETs are poorly defined. We identified 53 cystic PanNETs in our single-institution experience of 491 surgically resected PanNETs. Similar to solid PanNETs, cystic PanNETs developed with an equal sex distribution and over a wide age range (23 to 91 y; mean, 52 y). The unusual cystic appearance made radiologic differentiation from other cystic pancreatic neoplasms difficult with a misdiagnosis in 23 of 53 (43%) cases. An association between cystic PanNETs and multiple endocrine neoplasia type 1 or multifocal disease [5 of 53 (9%) and 7 of 53 (13%), respectively] was not observed as compared with solid PanNETs (P=0.34 and P=0.31, respectively). Grossly, cystic PanNETs were predominantly located in the tail of the pancreas (n=28, 53%) and were similar in size (mean, 3.3 cm) to solid PanNETs (mean, 4.1 cm; P=0.12). All cysts were unilocular (n=53, 100%) and filled with clear to straw-colored fluid. Larger cysts were sometimes noted to be hemorrhagic. Histologically, the cysts were lined by a thin fibrous band that separated the cyst from the neoplastic cells. In comparison with their solid counterparts, cystic PanNETs were less likely to demonstrate tumor necrosis (6%; P=0.04), perineural invasion (8%; P<0.001), vascular invasion (4%; P<0.001), regional lymph node metastasis (13%; P<0.001), and synchronous distant metastasis (4%; P=0.015). The neoplastic cells of the cystic PanNETs were well differentiated (n=53, 100%) with a low mitotic rate and low Ki-67 proliferation index (range, 0.2% to 11%; mean, 1.8%). On the basis of both the American Joint Cancer Committee and European Neuroendocrine Tumor Society staging systems, the majority of cystic PanNETs presented at a lower pathologic stage as compared with solid PanNETs. In summary, cystic PanNETs are a distinctive subgroup of PanNETs with unique clinical, radiographic, and pathologic features.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073325     DOI: 10.1097/PAS.0b013e31826a0048

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  25 in total

1.  Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.

Authors:  David J Worhunsky; Geoffrey W Krampitz; Peter D Poullos; Brendan C Visser; Pamela L Kunz; George A Fisher; Jeffrey A Norton; George A Poultsides
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

2.  Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT.

Authors:  Satomi Kawamoto; Pamela T Johnson; Chanjuan Shi; Aatur D Singhi; Ralph H Hruban; Christopher L Wolfgang; Barish H Edil; Elliot K Fishman
Journal:  AJR Am J Roentgenol       Date:  2013-03       Impact factor: 3.959

Review 3.  Recent advances in the diagnosis and management of pancreatic neuroendocrine tumours.

Authors:  Andrew D Hopper; Mustafa Jalal; Alia Munir
Journal:  Frontline Gastroenterol       Date:  2018-10-09

4.  A case of pancreatic neuroendocrine tumor with multiple cystic components of various sizes.

Authors:  Makiko Yasumoto; Yoshinobu Okabe; Gen Sugiyama; Yoshiki Naito; Masamichi Nakayama; Toru Hisaka; Hiroto Ishikawa; Hiroyuki Horiuchi; Yukiko Kunou; Tomoyuki Ushijima; Yusuke Ishida; Osamu Tsuruta; Takuji Torimura
Journal:  Clin J Gastroenterol       Date:  2017-12-21

5.  Pancreatic Neuroendocrine Tumors: an Update.

Authors:  Alessandro Paniccia; Barish H Edil; Richard D Schulick
Journal:  Indian J Surg       Date:  2015-10-13       Impact factor: 0.656

Review 6.  Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors.

Authors:  Masayuki Tanaka; Max Heckler; André L Mihaljevic; Pascal Probst; Ulla Klaiber; Ulrike Heger; Simon Schimmack; Markus W Büchler; Thilo Hackert
Journal:  Ann Surg Oncol       Date:  2020-07-27       Impact factor: 5.344

7.  Neuroendocrine neoplasm of pancreas with cystic degeneration mimicking mucinous cystic neoplasm.

Authors:  Uayporn Kaosombatwattana; Yoshiki Hirooka; Hiroki Kawashima; Eizaburo Ohno; Takuya Ishikawa; Hiroki Suhara; Hidemi Goto
Journal:  Clin J Gastroenterol       Date:  2018-03-13

Review 8.  Update on pancreatic neuroendocrine tumors.

Authors:  Logan R McKenna; Barish H Edil
Journal:  Gland Surg       Date:  2014-11

9.  Contrast-enhanced harmonic endoscopic ultrasound using time-intensity curve analysis predicts pathological grade of pancreatic neuroendocrine neoplasm.

Authors:  Saimon Takada; Hironari Kato; Yosuke Saragai; Shinichiro Muro; Daisuke Uchida; Takeshi Tomoda; Kazuyuki Matsumoto; Shigeru Horiguchi; Noriyuki Tanaka; Hiroyuki Okada
Journal:  J Med Ultrason (2001)       Date:  2019-08-03       Impact factor: 1.314

10.  Rapid shrinkage of a pancreatic serous cystadenoma with cystic degeneration: report of a case.

Authors:  Tatsuaki Sumiyoshi; Yasuo Shima; Takehiro Okabayashi; Akihito Kozuki; Toshio Nakamura; Jun Iwata; Yoshihiro Noda; Yasuhiro Hata; Yoriko Murata; Kiminori Uka; Sojiro Morita
Journal:  Surg Today       Date:  2014-07-03       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.